Latest / The Well-Built Life / Navigating COPD: Diagnosis, Management, and Exacerbations
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:08Speaker 1: you are tuning in. We are here to cut through
- 0:11Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:15Speaker 1: share simple, practical habits that help you feel stronger, healthier,
- 0:20Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:24Speaker 1: and let's dive in. So, Thomas, let's start by setting
- 0:28Speaker 1: the stage here. What exactly is SOAP and why should
- 0:32Speaker 1: our listeners be aware of it?
- 0:33Speaker 2: Definitely, Rachel. Chioped or chronic obstructive pulmonary disease is a
- 0:38Speaker 2: progressive lung condition. It's characterized by a persistent obstruction of
- 0:42Speaker 2: airflow from the lungs, making it harder and harder to
- 0:46Speaker 2: breathe over time. Right.
- 0:47Speaker 1: And that's the crucial nuance here. It's not just about
- 0:51Speaker 1: shortness of breath, but about a steady decline in lung
- 0:54Speaker 1: function that impacts quality of life significantly. What are the
- 0:58Speaker 1: primary causes of COPD?
- 1:00Speaker 2: Primarily, Pru OPD is caused by long-term exposure to harmful
- 1:04Speaker 2: substances such as tobacco smoke, and in occupational settings, it
- 1:08Speaker 2: can also be due to inhaling dust or fumes from
- 1:10Speaker 2: chemicals or asbestos. These irritants damage the airways over time,
- 1:15Speaker 2: leading to a buildup of mucus and narrowing of the
- 1:18Speaker 2: air passages.
- 1:19Speaker 1: So it's not just about smoking work environments can be
- 1:23Speaker 1: just as harmful.
- 1:25Speaker 2: Thomas.
- 1:26Speaker 1: Can you give us a sense of the impact on
- 1:28Speaker 1: the quality of life for someone with COPD?
- 1:30Speaker 2: Absolutely, Rachel. COPD can lead to significant respiratory distress, making
- 1:35Speaker 2: even simple tasks like walking upstairs or carrying groceries incredibly challenging.
- 1:40Speaker 2: Patients often have to limit their physical activities and may
- 1:43Speaker 2: experience chronic coughing and wheezing, which can be incredibly debilitating.
- 1:48Speaker 1: And it's not just about the physical limitations. The psychological
- 1:51Speaker 1: impact can be huge too. Depression and anxiety are common
- 1:56Speaker 1: among COPD patients due to the constant struggle with breathing
- 2:00Speaker 1: and the fear of severe exacerbations.
- 2:02Speaker 2: Exactly, which brings up an interesting contradiction. On the surface,
- 2:07Speaker 2: COP seems like a straightforward condition, but when you dig
- 2:10Speaker 2: into the mechanics, the incentives are very different. For instance,
- 2:15Speaker 2: patients with COP often feel guilty if they use their
- 2:18Speaker 2: oxygen tank during exercise, even though it's crucial for maintaining
- 2:21Speaker 2: their quality of life. Right.
- 2:24Speaker 1: Let's talk about early symptoms and why timely diagnosis is
- 2:28Speaker 1: so critical. Can you paint a picture of what a
- 2:31Speaker 1: COPD patient might experience early on?
- 2:34Speaker 2: Sure, Rachel. Early symptoms might include a persistent cough, shortness
- 2:38Speaker 2: of breath, especially during exertion, and a frequent need to
- 2:42Speaker 2: clear the throat. Sometimes patients might feel chest tightness or
- 2:45Speaker 2: experience recurrent wheezing. These symptoms can be easily overlooked or
- 2:50Speaker 2: mistaken for normal age-related changes in breathing. which is why
- 2:54Speaker 2: early diagnosis is crucial.
- 2:56Speaker 1: And how does COPD exacerbate in more serious cases? Why
- 3:01Speaker 1: is timely diagnosis important, especially in those cases?
- 3:05Speaker 2: Well, exacerbations are sudden increases in symptoms that aren't part
- 3:09Speaker 2: of the usual condition. These can be triggered by common
- 3:12Speaker 2: viruses like the flu or by new exposures such as
- 3:15Speaker 2: pollen or changes in weather. During an exacerbation, patients might
- 3:19Speaker 2: notice increased shortness of breath, increased coughing, more wheezing, and
- 3:24Speaker 2: maybe a change in the color or consistency of their sputum.
- 3:27Speaker 1: That's wild when you look at the raw numbers. Copy-D
- 3:31Speaker 1: exacerbations can lead to acute respiratory failure, which requires immediate
- 3:36Speaker 1: medical attention, as we have seen in our earlier material.
- 3:40Speaker 1: But timely diagnosis can mean the difference between a manageable
- 3:43Speaker 1: condition and one that spirals out of control.
- 3:46Speaker 2: Absolutely, Rachel. Early diagnosis allows for proactive management, reducing the
- 3:52Speaker 2: frequency and severity of exacerbations. It can also help in
- 3:56Speaker 2: identifying potential comorbidities that may need separate treatments.
- 4:00Speaker 1: So, as we move through the episode, we will cover
- 4:03Speaker 1: all these points and more. We want to arm our
- 4:06Speaker 1: listeners with the knowledge to recognize COPD early and take
- 4:10Speaker 1: the steps needed to manage it effectively. Thanks, Thomas. for
- 4:14Speaker 1: laying this groundwork.
- 4:16Speaker 2: Anytime, Rachel. Let's tackle this step by step and make
- 4:20Speaker 2: sure our listeners are well equipped.
- 4:22Speaker 1: So, let's dive into the ABCD assessment, Thomas. It's a
- 4:27Speaker 1: comprehensive way to triage and diagnose COPD, isn't it?
- 4:31Speaker 2: Absolutely, Rachel. The ABB assessment is really about stabilizing the
- 4:36Speaker 2: patient first. It ensures we address the most critical aspects
- 4:40Speaker 2: right from the get-go airway, breathing, circulation, disability, and exposure.
- 4:45Speaker 1: It's a handy mnemonic to remember all the crucial steps.
- 4:49Speaker 1: Can you walk us through each component? For instance, what
- 4:53Speaker 1: would we look for under the airway section?
- 4:56Speaker 2: Sure, Rachel. Under airway, we are essentially trying to ensure
- 5:00Speaker 2: the patient's airway is safe and clear. This means looking
- 5:04Speaker 2: for signs of airway obstruction, possible infection, and anything else
- 5:08Speaker 2: that could compromise breathing. Right.
- 5:11Speaker 1: And that's the crucial nuance here. So, if a patient
- 5:14Speaker 1: presents with wheezing or difficulty breathing, we'd be immediately addressing
- 5:18Speaker 1: these issues. It's like the difference between a house with
- 5:21Speaker 1: a strong foundation and one with a shaky one.
- 5:25Speaker 2: Exactly, which brings up an interesting contradiction. While stabilizing the
- 5:30Speaker 2: airway is critical, sometimes we might find that the patient's
- 5:34Speaker 2: breathing is compromised despite a seemingly stable airway. That's where
- 5:39Speaker 2: the breathing section comes in. We assess for signs of
- 5:43Speaker 2: respiratory distress, like increased work of breathing, low oxygen levels,
- 5:48Speaker 2: and altered mental status.
- 5:49Speaker 1: That does make sense. And let's say during this, we
- 5:53Speaker 1: discover a patient's oxygen saturation is below 92%. This could
- 5:59Speaker 1: indicate something's not right. Right?
- 6:02Speaker 2: Precisely. A saturation below 92% is a red flag. It
- 6:08Speaker 2: suggests the patient might be in respiratory distress, and we
- 6:12Speaker 2: D need to investigate further. This step might also involve
- 6:16Speaker 2: checking for signs of potential respiratory failure, like use of
- 6:20Speaker 2: accessory muscles and tachypnea.
- 6:23Speaker 1: I see. So, once we have done the initial ABC check,
- 6:26Speaker 1: the next step is the DE. What's the disability and
- 6:30Speaker 1: exposure sections all about?
- 6:31Speaker 2: The disability part, Rachel, is all about assessing the patient's
- 6:35Speaker 2: level of activity and mental status. We are looking for
- 6:38Speaker 2: changes that might indicate the severity of their condition. For example,
- 6:43Speaker 2: if a patient is more lethargic or has a more
- 6:45Speaker 2: difficult time breathing, that could point to COPD.
- 6:49Speaker 1: Makes sense. And exposure to me means looking for any
- 6:53Speaker 1: risk factors or triggers that might have caused or exacerbated
- 6:57Speaker 1: their symptoms. Like history of smoking or exposure to air pollutants, right?
- 7:03Speaker 2: Exactly. And this is where we get some really interesting insights,
- 7:07Speaker 2: especially in chronic cases. For instance, a history of frequent
- 7:11Speaker 2: colds could indicate an underlying COPD, or occupational hazards might
- 7:16Speaker 2: suggest exposure to harmful particles.
- 7:18Speaker 1: That's fascinating. And that transition to the next section really
- 7:23Speaker 1: sets the stage for the rest of the diagnosis. Now
- 7:26Speaker 1: let's move on to spirometry. Can you explain its importance?
- 7:30Speaker 2: Definitely, Rachel. Spirometry is a gold standard test in diagnosing COPD.
- 7:37Speaker 2: It helps us measure lung function and identify potential airflow obstructions.
- 7:42Speaker 2: We will start with pre-bronchodilator spirometry to get a baseline,
- 7:46Speaker 2: and if we see a ratio below 0.7 in the FeV1-FEC,
- 7:51Speaker 2: it could point to COPD.
- 7:53Speaker 1: Right, and post-bronchodilator spirometry comes next to see if there
- 7:58Speaker 1: is any reversibility in the obstruction. This step is crucial
- 8:02Speaker 1: because it helps distinguish COPD from other lung conditions.
- 8:07Speaker 2: Absolutely. And if the obstruction remains, it confirms the diagnosis.
- 8:12Speaker 2: It's like the final confirmation of the puzzle pieces coming together.
- 8:16Speaker 1: Exactly. And we use imaging techniques to rule out any
- 8:20Speaker 1: other conditions that might be causing similar symptoms. This could
- 8:24Speaker 1: include chest x-rays or CT scans to check for other issues.
- 8:30Speaker 1: like interstitial lung disease or heart failure.
- 8:33Speaker 2: True. These imaging tools add another layer of diagnostic certainty.
- 8:38Speaker 2: They help us paint a full picture of what's going
- 8:40Speaker 2: on inside the lungs and the heart.
- 8:42Speaker 1: So, in essence, the AGD assessment and these diagnostic tools
- 8:46Speaker 1: work together like a well-oiled machine. They ensure we catch
- 8:50Speaker 1: COPD early and manage it effectively. Right.
- 8:53Speaker 2: It's all about making sure our listeners are well-equipped with
- 8:56Speaker 2: the knowledge to recognize COPD early and manage it proactively.
- 9:00Speaker 1: Let's shift our focus to managing COPD once it's diagnosed. Thomas,
- 9:05Speaker 1: how do we approach treatment strategies for different severity levels?
- 9:09Speaker 2: Great transition, Rachel. The key is to tailor our approach
- 9:13Speaker 2: based on a patient's symptoms and the severity of their disease.
- 9:18Speaker 2: For instance, for milder cases... Lifestyle modifications and pharmacotherapy can
- 9:23Speaker 2: make a huge difference.
- 9:24Speaker 1: Exactly. Let's start with lifestyle modifications. For someone with mild COPD,
- 9:30Speaker 1: quitting smoking is absolutely critical. But we also want to
- 9:34Speaker 1: encourage regular exercise to improve their overall lung function and
- 9:38Speaker 1: cardiovascular health.
- 9:40Speaker 2: Right, and we shouldn't just focus on physical activity. Mental
- 9:44Speaker 2: health is also crucial. We might recommend practices like mindfulness
- 9:48Speaker 2: or deep breathing exercises to help alleviate anxiety and reduce breathlessness.
- 9:53Speaker 1: That's a great point. Now, moving on to pharmacotherapy. For
- 9:58Speaker 1: mild COPD … we might start with a single inhaled
- 10:01Speaker 1: long-acting bronchodilator, like a LABA or a fixed-dose Lama-Laba combination.
- 10:08Speaker 1: But how do these medications work exactly?
- 10:10Speaker 2: Well, bronchodilators work by relaxing the muscles around the airways,
- 10:14Speaker 2: making it easier to breathe. Imagine the airways are a
- 10:18Speaker 2: series of small tubes that sometimes get clogged. Medications like
- 10:22Speaker 2: albuterol or formoterol work by essentially lubricating and widening these tubes,
- 10:27Speaker 2: so air can flow more freely.
- 10:29Speaker 1: That's a great analogy. Now, what about supplemental oxygen? When
- 10:34Speaker 1: do we recommend it, and how does it help?
- 10:37Speaker 2: Supplemental oxygen is essential for patients with chronic hypoxemia. When
- 10:42Speaker 2: you see an oxygen saturation level below 88%, it's time
- 10:46Speaker 2: to consider supplemental oxygen. It helps maintain blood oxygen levels,
- 10:51Speaker 2: reducing the strain on the heart, and improving overall quality
- 10:54Speaker 2: of life.
- 10:55Speaker 1: Speaking of exacerbations, prevention is absolutely key. What strategies can
- 11:01Speaker 1: we recommend to patients to avoid COPD flare-ups?
- 11:04Speaker 2: Absolutely. We need to focus on avoidance strategies, ensuring patients
- 11:10Speaker 2: are up-to-date on all vaccinations, like the flu shot and
- 11:13Speaker 2: pneumococcal vaccine. can prevent infections that might exacerbate their condition. Also,
- 11:20Speaker 2: avoiding air pollution and secondhand smoke is crucial.
- 11:23Speaker 1: And what about for more severe cases? How do we
- 11:27Speaker 1: manage those?
- 11:27Speaker 2: For moderate to severe COPD, we might need a combination
- 11:31Speaker 2: of therapies. The addition of inhaled corticosteroids to the bronchodilator
- 11:36Speaker 2: regimen can help reduce inflammation and associated symptoms. But the
- 11:41Speaker 2: real challenge is managing frequent exacerbations and hospitalizations. True.
- 11:47Speaker 1: For these patients, we need to have a proactive management plan.
- 11:51Speaker 1: We could discuss how to use a rescue inhaler, if
- 11:54Speaker 1: symptoms worsen, and when to seek immediate medical attention.
- 11:58Speaker 2: Exactly. It's all about a holistic approach. We can't just
- 12:02Speaker 2: address the symptoms. We need to work with the patient
- 12:05Speaker 2: to minimize the impact of COP on their daily life.
- 12:08Speaker 2: and that involves a lot of patient education and support.
- 12:11Speaker 1: As we discussed earlier, an exacerbation can lead to significant
- 12:16Speaker 1: respiratory distress. But what exactly happens during this period? Thomas,
- 12:21Speaker 1: can you walk us through the typical signs we might
- 12:24Speaker 1: see in a patient?
- 12:25Speaker 2: Absolutely, Rachel. The key signs of respiratory failure during an
- 12:29Speaker 2: exacerbation are pretty telling. For instance, altered mental status indicates
- 12:34Speaker 2: a severe decline in oxygen levels. Use of accessory muscles
- 12:38Speaker 2: is another crucial sign. It suggests the respiratory muscles are
- 12:41Speaker 2: working overtime to compensate. A respiratory rate greater than 24
- 12:46Speaker 2: breaths per minute is also common, signaling the body's struggle
- 12:50Speaker 2: to keep up.
- 12:51Speaker 1: Right, and that's the crucial nuance here. These signs aren't
- 12:54Speaker 1: just symptoms. They are signaling a serious intervention is needed.
- 12:59Speaker 1: Moving on to arterial blood gas analysis. Thomas, can you
- 13:03Speaker 1: give us a rundown of what this entails?
- 13:05Speaker 2: Certainly. Arterial blood gas ABRG analysis is crucial because it
- 13:10Speaker 2: provides quantifiable data on oxygen and carbon dioxide levels and
- 13:14Speaker 2: pH which are key indicators of respiratory function. An ABG
- 13:19Speaker 2: showing acidosis, hypercarbia, or hypoxemia is a red flag signaling
- 13:24Speaker 2: the patient is in respiratory distress. For a mild exacerbation,
- 13:29Speaker 2: normal partial pressure of carbon dioxide is between 40-45 mmHg.
- 13:35Speaker 2: with a pH around 7.35 to 7.45. In moderate cases,
- 13:40Speaker 2: partial CO levels rise and pH can drop.
- 13:44Speaker 1: That's fascinating. So, for a mild exacerbation, the focus would
- 13:48Speaker 1: be on short-acting beta-2 agonists, Saba, and short-acting muscarinic antagonists, Sama,
- 13:58Speaker 1: with the possibility of oral corticosteroids like prednisone. Thomas, how
- 14:03Speaker 1: do these medications work to ease the symptoms. Exactly.
- 14:07Speaker 2: The sabas and samas help open up the airways, making
- 14:10Speaker 2: it easier for the patient to breathe. Corticosteroids reduce inflammation,
- 14:15Speaker 2: which can lead to better long-term outcomes. It's like putting
- 14:19Speaker 2: out a fire that's been smoldering, preventing it from escalating.
- 14:23Speaker 2: For a moderate exacerbation, we might need to escalate treatment
- 14:27Speaker 2: to include an intravenous corticosteroid and possibly an oral antibiotic.
- 14:32Speaker 2: given the presence of more severe symptoms and signs of infection.
- 14:36Speaker 1: Got it. And severe exacerbations are a whole different challenge, right? Thomas,
- 14:42Speaker 1: how do treatments differ?
- 14:43Speaker 2: Yes, very different. Severe COPD exacerbations involve more invasive measures,
- 14:49Speaker 2: like potentially initiating non-invasive mechanical ventilation. This is especially indicated
- 14:56Speaker 2: if teres respiratory acidosis, with oxygen saturation dipping below 88%.
- 15:02Speaker 2: In cases like this, we are talking about intravenous corticosteroids, antibiotics,
- 15:07Speaker 2: and even in some cases, intubation and mechanical ventilation as
- 15:11Speaker 2: a last resort. The goal is to stabilize the patient
- 15:14Speaker 2: quickly and effectively.
- 15:16Speaker 1: This is also critical. It's amazing how such a small
- 15:19Speaker 1: change in numbers can mean the difference between living with
- 15:22Speaker 1: the condition and managing it effectively or risking a severe decline.
- 15:27Speaker 1: How does the diagnostic process post-exacerbation help in this context?
- 15:31Speaker 2: Diagnosing post-exacerbation is vital. We use spirometry and labs to
- 15:38Speaker 2: confirm the COP diagnosis and assess the severity. A low
- 15:42Speaker 2: FeV1-TeVc ratio confirms non-reversible airflow obstruction, and this helps tailor
- 15:49Speaker 2: the management plan. For example, mild exacerbations might just need
- 15:54Speaker 2: supportive care. while moderate to severe cases require more aggressive treatment.
- 15:59Speaker 1: And the dyspnea visual analog scale, VAS, helps us gauge
- 16:02Speaker 1: the patient's perceived severity, providing valuable subjective data. It's all
- 16:08Speaker 1: about balancing the objective data from ABG and spirometry with
- 16:12Speaker 1: the patient's feedback. Thomas, what's the takeaway here for our listeners?
- 16:17Speaker 2: For our listeners, the key takeaway is that managing COPD
- 16:21Speaker 2: requires a proactive, holistic approach. From regular checkups and spirometry
- 16:26Speaker 2: to understanding the signs of an exacerbation and knowing when
- 16:30Speaker 2: to seek professional help, we can empower our listeners to
- 16:33Speaker 2: take charge of their health. It's about being vigilant and
- 16:36Speaker 2: responsive to changes in their body.
- 16:38Speaker 1: As we look ahead, Thomas, new therapies and strategies are emerging,
- 16:43Speaker 1: but they come with their own set of challenges. What
- 16:47Speaker 1: do you think is the most promising development in COPD
- 16:50Speaker 1: management right now?
- 16:51Speaker 2: That's an interesting question, Rachel. One of the most promising
- 16:55Speaker 2: developments is the advancement in personalized medicine. For instance, genetic
- 17:00Speaker 2: testing can now identify specific biomarkers that predict how a
- 17:03Speaker 2: patient might respond to certain treatments. This allows for a
- 17:07Speaker 2: more tailored approach, improving treatment outcomes.
- 17:10Speaker 1: Right, and that's the crucial nuance here. But how does
- 17:13Speaker 1: that actually play out in practice? Can you take us
- 17:17Speaker 1: through an example?
- 17:18Speaker 2: Sure. Let's say we have a patient with COPD, a
- 17:21Speaker 2: long-time smoker. genetic testing reveals they have a higher risk
- 17:25Speaker 2: of responding well to an inhaled corticosteroid. So instead of
- 17:30Speaker 2: prescribing a broad-spectrum medication, we can start with a targeted corticosteroid.
- 17:35Speaker 2: This not only improves the effectiveness of the treatment, but
- 17:39Speaker 2: also reduces unnecessary side effects.
- 17:41Speaker 1: That's wild when you look at the raw numbers. But
- 17:44Speaker 1: what about the challenges in implementing these personalized therapies? Cost? Accessibility?
- 17:51Speaker 1: And patient compliance, right?
- 17:53Speaker 2: Exactly, which brings up an interesting contradiction. While personalized medicine
- 17:58Speaker 2: is fascinating, it also raises concerns about affordability. The cost
- 18:02Speaker 2: of these tests and tailor-made treatments can be prohibitive for
- 18:05Speaker 2: a lot of patients. Plus, to raise the issue of
- 18:09Speaker 2: patient education and compliance, can people actually follow the prescribed regimen? True.
- 18:15Speaker 1: And on a broader scale, how do we ensure equitable
- 18:18Speaker 1: access to these new therapies? The healthcare system needs to adapt,
- 18:23Speaker 1: and that means addressing systemic barriers.
- 18:26Speaker 2: Absolutely. We need to see more integration of patient-centric care models.
- 18:31Speaker 2: Hospitals and primary care providers should work together to ensure
- 18:35Speaker 2: these new treatments are rolled out effectively. It's not just
- 18:38Speaker 2: about having the tools but making sure they are used appropriately.
- 18:42Speaker 1: That's a good segue. Let's talk about long-term strategies then.
- 18:47Speaker 1: How do we prepare patients and their caregivers for managing
- 18:50Speaker 1: COPD over the long term?
- 18:52Speaker 2: Long-term management really boils down to education and support. Patients
- 18:57Speaker 2: need to understand what triggers exacerbations and how to manage them.
- 19:02Speaker 2: For instance, knowing the signs of an exacerbation and how
- 19:06Speaker 2: to initiate treatment early can prevent hospitalization.
- 19:10Speaker 1: Exactly. And this requires more than just education. It needs
- 19:15Speaker 1: a robust support network, How do we build that?
- 19:18Speaker 2: A comprehensive approach is key. Community programs that offer peer support,
- 19:22Speaker 2: regular check-ins with health care providers, and support groups are
- 19:26Speaker 2: all crucial. Also, incorporating technology like remote monitoring and telemedicine
- 19:31Speaker 2: can make follow-ups more convenient.
- 19:32Speaker 1: That's a pragmatic solution. Lastly, what about the role of
- 19:37Speaker 1: public health initiatives in COCPD management?
- 19:41Speaker 2: Public health initiatives are vital. They can reduce the incidence
- 19:44Speaker 2: of COHT through prevention programs like smoking cessation, air quality improvements,
- 19:50Speaker 2: and education campaigns. These initiatives not only save lives, but
- 19:54Speaker 2: also reduce the burden on our healthcare systems.
- 19:57Speaker 1: Summing it up, Thomas, it's a multifaceted approach, personalized medicine,
- 20:02Speaker 1: long-term management strategies, and public health initiatives. It sounds complex,
- 20:07Speaker 1: but tackling each piece bit by bit can significantly improve
- 20:10Speaker 1: outcomes for COPD patients.
- 20:12Speaker 2: Precisely, Rachel. And by working together, we can make a
- 20:16Speaker 2: meaningful difference in the lives of those living with COPD.
- 20:19Speaker 1: That brings us to the end of today's episode. Thank
- 20:22Speaker 1: you so much for spending part of your day with me.
- 20:25Speaker 1: If you found this episode's tips helpful and want to
- 20:28Speaker 1: make sure you don't miss the next conversation, please take
- 20:31Speaker 1: a quick second to hit that subscribe or follow button
- 20:34Speaker 1: on whatever platform you are listening on. It's a completely
- 20:37Speaker 1: free way to support the show and helps more people
- 20:39Speaker 1: find us. This podcast is independently produced, so if you
- 20:43Speaker 1: are ever in a position where you would like to
- 20:45Speaker 1: help keep it running, we do accept small donations. You
- 20:49Speaker 1: can find a link right in the episode description below
- 20:52Speaker 1: to buy us a coffee or contribute what you can.
- 20:56Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 21:00Speaker 1: and we will talk again soon.